CHINA PHARMA HOLDINGS, INC. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
Zhilin Li, CEO and interim CFO, certified the Q2 2026 (ended June 30, 2026) Form 10-Q on August 14, 2026, per Sarbanes-Oxley Sections 302 and 906. Certifications state no material misstatements, fair presentation of financials, and adequate disclosure controls. No specific financial data, transactions, or operational changes are disclosed in these certification exhibits.
Why this rating
Boilerplate SOX certifications with no material transaction, financial figure, or operational event disclosed. Routine quarterly filing requirement.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.